AROA BIOSURGERY LIMITED ARBN 638 867 473 NZCN 1980577 64 Richard Pearse Drive, Auckland 2022, New Zealand AROA.COM ASX ANNOUNCEMENT 29 September 2026 I N V I T E T O I N V E S T O R W E B I N A R O N M A S T R R I N T E R I M A N A L Y S I S Aroa Biosurgery Limited (ASX: ARX, ‘AROA’ or the...
Invite to Investor Webinar on MASTRR Interim Analysis
Filed with ASX · · 1 page · English
Release
Story so far
Earlier from Aroa Biosurgery
- Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction
- Myriad MASTRR Study Reports Low Infection Rates
- Change of Director's Interest Notice - BW
- Notification regarding unquoted securities - ARX
- Final Director's Interest Notice - JD
Later from Aroa Biosurgery
- Symphony Significantly Improves DFU Healing
- Symphony™ Randomized Controlled Trial Demonstrates Significantly Improved Healing of Diabetic Foot Ulcers
- Change in substantial holding
- Investor Presentation - MASTRR Interim Analysis
- Invite to Investor Webinar on Symphony RCT
Follow Aroa Biosurgery into a list and get an email when it puts out news.
Follow Aroa Biosurgery